Skip to contents
In This Issue:
Daphne Haas-Kogan, MD, has been appointed chair of the Department of Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), effective July 1, 2015. She will be appointed professor at Harvard Medical School and will also be the endowed professor of Radiation Oncology at BWHC. Haas-Kogan succeeds Jay Harris, MD, who announced his decision to step down as chair in June 2013.
Haas-Kogan will join DF/BWCC from the University of California, San Francisco (UCSF), where she is currently program director and vice chair in the Department of Radiation Oncology at the Helen Diller Family Comprehensive Care Center and UCSF Benioff Children’s Hospital, and professor of Radiation Oncology and Neurological Surgery. She previously served as the residency program director and vice chair for Research and Education in the Department of Radiation Oncology.
She has an active laboratory-based research program that investigates novel therapeutic agents for adult and childhood brain tumors, as well as pediatric malignancies. Haas-Kogan is the principle investigator for several clinical trials, including investigator-initiated studies and cooperative group trials run by the Children’s Oncology Group and the Pacific-Pediatric Neuro-Oncology Consortium. A widely published author, she has also received accolades for excellence in teaching and exceptional care delivery.
Haas-Kogan received her bachelor’s degree in biochemistry and molecular biology from Harvard University and her medical degree from the UCSF School of Medicine. She completed her internal medicine residency at California Pacific Medical Center and her radiation oncology residency at UCSF, where she also was chief resident and a postdoctoral fellow.
“We are delighted that Dr. Haas-Kogan will join our team to lead Radiation Oncology,” said BWH President Betsy Nabel, MD. “A thoughtful and collaborative leader, she brings a depth of experience in patient care, research and teaching, which will enrich our Radiation Oncology service and benefit the patients we serve. We are immensely grateful to Dr. Harris for his unwavering leadership for more than 15 years, as well as his dedication to innovation, his passion for training and education and his commitment to providing exceptional care to our patients and families.”